Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Mar;61(3):436–440. doi: 10.1038/bjc.1990.96

A prognostic score in histological node negative breast cancer.

B Chevallier 1, V Mosseri 1, J P Dauce 1, P Bastit 1, J P Julien 1, B Asselain 1
PMCID: PMC1971289  PMID: 2328212

Abstract

Between October 1977 and December 1983, 379 consecutive patients have been treated for unilateral, non-metastatic breast cancer, either with conservative (n = 205) or radical surgery (n = 174), with axillary dissection in all the cases. None of them had histologically proved lymph node involvement. Oestrogen receptor (ER) and progesterone receptor (PR) levels were measured on each tumour. Levels greater than 5 fmol mg-1 cytosolic protein were considered as positive for both ER and PR. At 5 years, overall survival (OS) and disease-free survival (DFS) are respectively 88% and 78%. Unifactorial analysis using Kaplan and Meier estimates and the log rank test revealed that OS was significantly related to age (P less than 0.05), tumour size (P less than 0.001), histological grading (SBR) (P less than 0.01), ER (P less than 0.001) and PR (P less than 0.001). DFS was significantly related to the same factors. Menopausal status, number of breast tumour foci and previous familial history of breast cancer were not significant. Multifactorial analysis revealed that DFS was significantly related to age (bad prognosis (b.p.) less than or equal to 37 years old), tumour size and histological grading (b.p. SBR = 3), and that OS was significantly related to tumour size and PR (b.p. PR less than or equal to 5 fmol mg-1 protein). A prognostic score has been constructed for both DFS and OS. These scores divide our patients into three significantly different (P less than 0.0001) groups with good, intermediate and bad prognosis.

Full text

PDF
436

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adami H. O., Malker B., Holmberg L., Persson I., Stone B. The relation between survival and age at diagnosis in breast cancer. N Engl J Med. 1986 Aug 28;315(9):559–563. doi: 10.1056/NEJM198608283150906. [DOI] [PubMed] [Google Scholar]
  2. Albano W. A., Hanf C. D., Organ C. H., Jr Natural history of lymph-node-negative breast cancer. Surgery. 1979 Oct;86(4):574–577. [PubMed] [Google Scholar]
  3. BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bauer T. W., O'Ceallaigh D., Eggleston J. C., Moore G. W., Baker R. R. Prognostic factors in patients with stage I, estrogen receptor-negative carcinoma of the breast. A clinicopathologic study. Cancer. 1983 Oct 15;52(8):1423–1431. doi: 10.1002/1097-0142(19831015)52:8<1423::aid-cncr2820520815>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  5. Bulbrook R. D. Prognostic factors and tumour markers in early breast cancer; a commentary. Eur J Cancer Clin Oncol. 1983 Dec;19(12):1693–1697. doi: 10.1016/0277-5379(83)90154-2. [DOI] [PubMed] [Google Scholar]
  6. Clark G. M., McGuire W. L., Hubay C. A., Pearson O. H., Marshall J. S. Progesterone receptors as a prognostic factor in Stage II breast cancer. N Engl J Med. 1983 Dec 1;309(22):1343–1347. doi: 10.1056/nejm198312013092240. [DOI] [PubMed] [Google Scholar]
  7. Fisher B., Bauer M., Wickerham D. L., Redmond C. K., Fisher E. R., Cruz A. B., Foster R., Gardner B., Lerner H., Margolese R. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer. 1983 Nov 1;52(9):1551–1557. doi: 10.1002/1097-0142(19831101)52:9<1551::aid-cncr2820520902>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  8. Fisher B., Slack N. H., Bross I. D. Cancer of the breast: size of neoplasm and prognosis. Cancer. 1969 Nov;24(5):1071–1080. doi: 10.1002/1097-0142(196911)24:5<1071::aid-cncr2820240533>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  9. Haybittle J. L., Blamey R. W., Elston C. W., Johnson J., Doyle P. J., Campbell F. C., Nicholson R. I., Griffiths K. A prognostic index in primary breast cancer. Br J Cancer. 1982 Mar;45(3):361–366. doi: 10.1038/bjc.1982.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Høst H., Lund E. Age as a prognostic factor in breast cancer. Cancer. 1986 Jun 1;57(11):2217–2221. doi: 10.1002/1097-0142(19860601)57:11<2217::aid-cncr2820571124>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  11. Kallioniemi O. P., Blanco G., Alavaikko M., Hietanen T., Mattila J., Lauslahti K., Koivula T. Tumour DNA ploidy as an independent prognostic factor in breast cancer. Br J Cancer. 1987 Nov;56(5):637–642. doi: 10.1038/bjc.1987.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  13. Mason B. H., Holdaway I. M., Mullins P. R., Yee L. H., Kay R. G. Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res. 1983 Jun;43(6):2985–2990. [PubMed] [Google Scholar]
  14. Moot S. K., Peters G. N., Cheek J. H. Tumor hormone receptor status and recurrences in premenopausal node negative breast carcinoma. Cancer. 1987 Aug 1;60(3):382–385. doi: 10.1002/1097-0142(19870801)60:3<382::aid-cncr2820600316>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  15. Nealon T. F., Jr, Nkongho A., Grossi C., Gillooley J. Pathologic identification of poor prognosis stage I (T1N0M0) cancer of the breast. Ann Surg. 1979 Aug;190(2):129–132. doi: 10.1097/00000658-197908000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nemoto T., Vana J., Bedwani R. N., Baker H. W., McGregor F. H., Murphy G. P. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer. 1980 Jun 15;45(12):2917–2924. doi: 10.1002/1097-0142(19800615)45:12<2917::aid-cncr2820451203>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  17. Parl F. F., Schmidt B. P., Dupont W. D., Wagner R. K. Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading. Cancer. 1984 Nov 15;54(10):2237–2242. doi: 10.1002/1097-0142(19841115)54:10<2237::aid-cncr2820541029>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  18. Sears H. F., Janus C., Levy W., Hopson R., Creech R., Grotzinger P. Breast cancer without axillary metastases. Are there high-risk biologic subpopulations? Cancer. 1982 Nov 1;50(9):1820–1827. doi: 10.1002/1097-0142(19821101)50:9<1820::aid-cncr2820500928>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  19. Silvestrini R., Daidone M. G., Di Fronzo G., Morabito A., Valagussa P., Bonadonna G. Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer. Breast Cancer Res Treat. 1986;7(3):161–169. doi: 10.1007/BF01806246. [DOI] [PubMed] [Google Scholar]
  20. Stewart J. F., Rubens R. D., Millis R. R., King R. J., Hayward J. L. Steroid receptors and prognosis in operable (stage I and II) breast cancer. Eur J Cancer Clin Oncol. 1983 Oct;19(10):1381–1387. doi: 10.1016/0277-5379(93)90007-r. [DOI] [PubMed] [Google Scholar]
  21. Thorpe S. M., Rose C., Rasmussen B. B., Mouridsen H. T., Bayer T., Keiding N. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Cancer Res. 1987 Nov 15;47(22):6126–6133. [PubMed] [Google Scholar]
  22. Trojani M., de Mascarel I., Bonichon F., Coindre J. M., Delsol G. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer. 1987 Mar;55(3):303–306. doi: 10.1038/bjc.1987.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tubiana M., Pejovic M. H., Chavaudra N., Contesso G., Malaise E. P. The long-term prognostic significance of the thymidine labelling index in breast cancer. Int J Cancer. 1984 Apr 15;33(4):441–445. doi: 10.1002/ijc.2910330404. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES